PL366379A1 - Terapie kombinowane z aktywnością uszkadzania naczyń - Google Patents

Terapie kombinowane z aktywnością uszkadzania naczyń

Info

Publication number: PL366379A1
Authority: PL; Poland
Prior art keywords: vascular damaging; combination therapies; damaging activity; taxane; warm
Prior art date: 2000-03-31

Application number

PL01366379A

Other languages

English (en)

Inventor

Peter David Davis

Graeme Dougherty

Original Assignee

Angiogene Pharmaceuticals Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-31

Filing date

2001-03-27

Publication date

2005-01-24

2000-03-31 Priority claimed from GB0007740A external-priority patent/GB0007740D0/en

2000-06-08 Priority claimed from GB0013927A external-priority patent/GB0013927D0/en

2000-06-20 Priority claimed from GB0014908A external-priority patent/GB0014908D0/en

2001-03-27 Application filed by Angiogene Pharmaceuticals Ltd. filed Critical Angiogene Pharmaceuticals Ltd.

2005-01-24 Publication of PL366379A1 publication Critical patent/PL366379A1/pl

Links

230000000254 damaging effect Effects 0.000 title abstract 3
230000002792 vascular Effects 0.000 title abstract 3
238000002648 combination therapy Methods 0.000 title 1
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 4
241001465754 Metazoa Species 0.000 abstract 3
238000004519 manufacturing process Methods 0.000 abstract 3
229940123237 Taxane Drugs 0.000 abstract 2
239000002246 antineoplastic agent Substances 0.000 abstract 2
229910052697 platinum Inorganic materials 0.000 abstract 2
DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 abstract 2
238000002560 therapeutic procedure Methods 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 1
230000005865 ionizing radiation Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Glass Compositions (AREA)

PL01366379A 2000-03-31 2001-03-27 Terapie kombinowane z aktywnością uszkadzania naczyń PL366379A1 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0007740A GB0007740D0 (en)	2000-03-31	2000-03-31	Combination therapy
GB0013927A GB0013927D0 (en)	2000-06-08	2000-06-08	Combination therapy
GB0014908A GB0014908D0 (en)	2000-06-20	2000-06-20	Combination therapy

Publications (1)

Publication Number	Publication Date
PL366379A1 true PL366379A1 (pl)	2005-01-24

Family

ID=27255634

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL01366379A PL366379A1 (pl)	2000-03-31	2001-03-27	Terapie kombinowane z aktywnością uszkadzania naczyń

Country Status (23)

Country	Link
US (2)	US6906048B2 (pl)
EP (1)	EP1272199B1 (pl)
JP (1)	JP2003528920A (pl)
KR (1)	KR20020087456A (pl)
CN (1)	CN1430515A (pl)
AT (1)	ATE287267T1 (pl)
AU (2)	AU4258101A (pl)
BR (1)	BR0109672A (pl)
CA (1)	CA2402539A1 (pl)
CZ (1)	CZ20023228A3 (pl)
DE (1)	DE60108489T2 (pl)
EE (1)	EE200200565A (pl)
ES (1)	ES2236199T3 (pl)
HU (1)	HUP0300290A3 (pl)
IL (1)	IL151628A0 (pl)
IS (1)	IS6558A (pl)
MX (1)	MXPA02009604A (pl)
NO (1)	NO20024646L (pl)
NZ (1)	NZ521025A (pl)
PL (1)	PL366379A1 (pl)
PT (1)	PT1272199E (pl)
SK (1)	SK13912002A3 (pl)
WO (1)	WO2001074368A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070021392A1 (en) *	2000-03-31	2007-01-25	Davis Peter D	Divided dose therapies with vascular damaging activity
GB0011903D0 (en) *	2000-05-18	2000-07-05	Astrazeneca Ab	Combination chemotherapy
FR2834641B1 (fr) *	2002-01-14	2005-04-22	Ct Regional De Lutte Contre Le	Protection de la neurotoxicite de l'oxaliplatine par administration de calcium et de magnesium
BR0309226A (pt) *	2002-04-16	2005-02-09	Astrazeneca Ab	Métodos para a produção de um efeito de danificação vascular em um animal de sangue quente, e para o tratamento de um câncer envolvendo um tumor sólido em um animal de sangue quente, composição farmacêutica, kit, e, usos de zd6126 ou de um seu sal farmaceuticamente aceitável, e de zd1839 ou de um seu sal farmaceuticamente aceitável
GB0223379D0 (en) *	2002-10-09	2002-11-13	Angiogene Pharm Ltd	Combination therapy
FR2848212B1 (fr) *	2002-12-06	2006-10-27	Aventis Pharma Sa	Derives de la colchicine, procede de preparation, produits obtenus par ce procede et utilisation
JP2006527753A (ja) *	2003-06-18	2006-12-07	アンギオジェン・ファーマシューティカルズ・リミテッド	結腸直腸癌などの治療のための、血管損傷効果を有する、５−ｆｕ、ｃｐｔ−１１または５−ｆｕおよびｃｐｔ−１１と組み合わせたｚｄ６１２６を含んでなる組成物
GB0316123D0 (en) *	2003-07-10	2003-08-13	Astrazeneca Ab	Combination therapy
US9149489B2 (en) *	2006-04-27	2015-10-06	Board Of Regents, University Of Texas System	Inhibitors of glycolysis useful in the treatment of brain tumors
US8178564B2 (en) *	2006-11-06	2012-05-15	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US8168662B1 (en)	2006-11-06	2012-05-01	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US8173686B2 (en)	2006-11-06	2012-05-08	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US8168661B2 (en) *	2006-11-06	2012-05-01	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) *	2009-08-05	2011-02-10	Poniard Pharmaceuticals, Inc.	Stabilized picoplatin oral dosage form
US20100260832A1 (en) *	2007-06-27	2010-10-14	Poniard Pharmaceuticals, Inc.	Combination therapy for ovarian cancer
TW200916094A (en) *	2007-06-27	2009-04-16	Poniard Pharmaceuticals Inc	Stabilized picoplatin dosage form
US20100310661A1 (en) *	2007-07-16	2010-12-09	Poniard Pharmaceuticals, Inc.	Oral formulations for picoplatin
CA2715348A1 (en) *	2008-02-08	2009-08-13	Poniard Pharmaceuticals, Inc.	Use of picoplatin and bevacizumab to treat colorectal cancer
TWI492759B (zh) *	2008-03-05	2015-07-21	Otsuka Pharma Co Ltd	膽甾烷醇衍生物之併用用途
ES2628180T3 (es)	2008-07-11	2017-08-02	Board Of Regents, The University Of Texas System	Nuevos acetatos de 2-desoxi monosacáridos con actividad anticancerosa
KR101106214B1 (ko) *	2011-04-04	2012-01-20	홍오성	감귤 내껍질 분리 장치
PL2981270T3 (pl)	2013-04-05	2022-05-09	Board Of Regents, The University Of Texas System	Estry 2-deoksy-monosacharydów o działaniu przeciwproliferacyjnym

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9714249D0 (en) *	1997-07-08	1997-09-10	Angiogene Pharm Ltd	Vascular damaging agents
AU762615B2 (en) *	1998-06-15	2003-07-03	Arch Development Corporation	Combination of radiotherapy and anti-angiogenic factors
GB9903404D0 (en)	1999-02-16	1999-04-07	Angiogene Pharm Ltd	Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis
PL357282A1 (pl)	2000-03-31	2004-07-26	Angiogene Pharmaceuticals Ltd.	Terapie z zastosowaniem dawki podzielonej o działaniu uszkadzającym naczynia krwionośne

2001
- 2001-02-27 EE EEP200200565A patent/EE200200565A/xx unknown
- 2001-03-27 HU HU0300290A patent/HUP0300290A3/hu unknown
- 2001-03-27 AT AT01915490T patent/ATE287267T1/de not_active IP Right Cessation
- 2001-03-27 CZ CZ20023228A patent/CZ20023228A3/cs unknown
- 2001-03-27 JP JP2001572111A patent/JP2003528920A/ja active Pending
- 2001-03-27 PT PT01915490T patent/PT1272199E/pt unknown
- 2001-03-27 EP EP01915490A patent/EP1272199B1/en not_active Expired - Lifetime
- 2001-03-27 ES ES01915490T patent/ES2236199T3/es not_active Expired - Lifetime
- 2001-03-27 IL IL15162801A patent/IL151628A0/xx unknown
- 2001-03-27 US US10/240,213 patent/US6906048B2/en not_active Expired - Fee Related
- 2001-03-27 DE DE60108489T patent/DE60108489T2/de not_active Expired - Fee Related
- 2001-03-27 KR KR1020027013061A patent/KR20020087456A/ko not_active Ceased
- 2001-03-27 PL PL01366379A patent/PL366379A1/pl not_active Application Discontinuation
- 2001-03-27 BR BR0109672-9A patent/BR0109672A/pt not_active IP Right Cessation
- 2001-03-27 NZ NZ521025A patent/NZ521025A/en unknown
- 2001-03-27 CN CN01807444A patent/CN1430515A/zh active Pending
- 2001-03-27 SK SK1391-2002A patent/SK13912002A3/sk not_active Application Discontinuation
- 2001-03-27 WO PCT/GB2001/001317 patent/WO2001074368A1/en not_active Ceased
- 2001-03-27 CA CA002402539A patent/CA2402539A1/en not_active Abandoned
- 2001-03-27 AU AU4258101A patent/AU4258101A/xx active Pending
- 2001-03-27 MX MXPA02009604A patent/MXPA02009604A/es unknown
- 2001-03-27 AU AU2001242581A patent/AU2001242581B2/en not_active Ceased
2002
- 2002-09-20 IS IS6558A patent/IS6558A/is unknown
- 2002-09-27 NO NO20024646A patent/NO20024646L/no unknown
2004
- 2004-11-23 US US10/994,639 patent/US20050107346A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PT1272199E (pt)	2005-05-31
NO20024646L (no)	2002-10-15
CN1430515A (zh)	2003-07-16
CZ20023228A3 (cs)	2003-01-15
JP2003528920A (ja)	2003-09-30
AU2001242581B2 (en)	2005-03-03
AU4258101A (en)	2001-10-15
SK13912002A3 (sk)	2003-05-02
HUP0300290A3 (en)	2005-12-28
EP1272199B1 (en)	2005-01-19
DE60108489T2 (de)	2006-03-30
US6906048B2 (en)	2005-06-14
NO20024646D0 (no)	2002-09-27
ATE287267T1 (de)	2005-02-15
CA2402539A1 (en)	2001-10-11
US20050107346A1 (en)	2005-05-19
HUP0300290A2 (hu)	2003-06-28
EE200200565A (et)	2004-06-15
BR0109672A (pt)	2003-02-04
DE60108489D1 (de)	2005-02-24
IL151628A0 (en)	2003-04-10
US20030166617A1 (en)	2003-09-04
WO2001074368A1 (en)	2001-10-11
IS6558A (is)	2002-09-20
EP1272199A1 (en)	2003-01-08
MXPA02009604A (es)	2003-03-10
KR20020087456A (ko)	2002-11-22
NZ521025A (en)	2005-06-24
ES2236199T3 (es)	2005-07-16

Legal Events

Date	Code	Title	Description
2008-09-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
AU4258101A (en)	2001-10-15	Combination therapies with vascular damaging activity
AP1760A (en)	2007-07-18	Platinum derivative pharmaceutical formulations.
YU71901A (sh)	2005-07-19	NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
WO2004045593A3 (en)	2004-08-12	Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
JO2373B1 (en)	2006-12-12	W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
MY143795A (en)	2011-07-15	Tetrahydropyridoindole derivatives
PL1664016T3 (pl)	2009-04-30	Środki terapeutyczne przydatne do leczenia bólu
PL374443A1 (pl)	2005-10-17	Nowe pochodne pirymidynoamidów oraz ich zastosowanie
WO2001030802A3 (en)	2002-02-14	Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
CA2235412A1 (en)	1997-05-01	Pharmaceutical composition containing an activin or inhibin stimulator
IL164564A0 (en)	2005-12-18	Combination therapy for the treatment of cancer
IS6555A (is)	2002-10-18	Meðferð með aðskildum skömmtum sem hafa æðaskaðandi virkni
NO20051261L (no)	2005-03-11	Morfin-6-glukuronidsalt
TW200501958A (en)	2005-01-16	A therapeutic agent for treating a behavioral disorder
DE60309926D1 (de)	2007-01-04	Steroid-verbindungen mit anti-tumoraler wirkung
FR2809725B1 (fr)	2004-05-07	Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant
WO2005035500A3 (en)	2005-05-19	Therapeutic agents useful for treating pain
ZA200605900B (en)	2008-02-27	Glycosylated steroid derivatives with anti-migratory activity
TW200500073A (en)	2005-01-01	Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof
UA31379A (uk)	2000-12-15	Спосіб лікування ішемічної хвороби серця